Delayed second Pfizer-BioNTech shot produces more antibodies, U.K. study says May 14, 2021 Canadian vaccine experts say a British study that showed a boost in immune response among seniors who received their second Pfizer-BioNTech shot later supports Canada's dose-spacing strategy. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.